ANAPTYSBIO, INC. Common Stock, Capital Shares Reserved for Future Issuance
ANAPTYSBIO, INC. (ANAB) had Common Stock, Capital Shares Reserved for Future Issuance of 8.50 million shares as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2023-03-01
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.50M shares.
- 2022-09-30: Common Stock, Capital Shares Reserved for Future Issuance 8.66M shares.
- 2022-06-30: Common Stock, Capital Shares Reserved for Future Issuance 8.78M shares.
- 2022-03-31: Common Stock, Capital Shares Reserved for Future Issuance 8.83M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2022-12-31 | 8.50M shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 8.66M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 8.78M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 8.83M shares 10-Q · filed 2022-05-04 |
| 2021-12-31 | 7.98M shares 10-K · filed 2022-03-07 |
| 2021-09-30 | 8.17M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 8.20M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 8.26M shares 10-Q · filed 2021-05-04 |
| 2020-12-31 | 6.90M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 6.91M shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 6.97M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 6.98M shares 10-Q · filed 2020-05-06 |
| 2019-12-31 | 5.64M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 5.80M shares 10-Q · filed 2019-11-08 |
| 2019-06-30 | 5.85M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 5.89M shares 10-Q · filed 2019-05-07 |
| 2018-12-31 | 4.63M shares 10-K · filed 2019-02-28 |
| 2018-09-30 | 4.80M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 4.99M shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 5.20M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 3.82M shares 10-K · filed 2018-03-05 |
| 2017-09-30 | 3.85M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 4.09M shares 10-Q · filed 2017-08-10 |
| 2017-03-31 | 4.13M shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |